Page 306 - 73_04

RAFAEL MAYORAL Y COLS. ANAL. REAL ACAD. NAC. FARM.

REFERENCIAS

(1) PALADE, G. E. (1953) Fine structure of blood capillaries. J. Appl. Physics. 24:
(2) 368–384.
(3) YAMADA, E. (1955) The fine structure of the gall bladder epithelium of the
(4) mouse. J. Biophys. Biochem. Cytol. 1: 445-458.
KURZCHALIA, T. V. AND PARTON, R. G. (1999) Membrane microdomains and
(5) caveolae. Curr. Opin. Cell. Biol. 11: 424-431.
SCHERER, P. E., LEWIS, R. Y., VOLONTE, D., ENGELMAN, J. A., GALBIATI, F., COUET,
(6) J., KOHTZ, D. S., VAN DONSELAAR, E., PETERS, P. AND LISANTI, M. P. (1997) Cell-
(7) type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-
(8) localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem.
(9) 272: 29337-29346.
SONG, K. S., SCHERER, P. E., TANG, Z., OKAMOTO, T., LI, S., CHAFEL, M., CHU,
(10) C., KOHTZ, D. S. AND LISANTI, M. P. (1996) Expression of caveolin-3 in ske-
(11) letal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the
sarcolemma and co-fractionates with dystrophin and dystrophin-associated
(12) glycoproteins. J. Biol. Chem. 271: 15160-15165.
SCHNITZER, J. E. (2001) Caveolae: from basic trafficking mechanisms to tar-
(13) geting transcytosis for tissue-specific drug and gene delivery in vivo. Adv.
Drug Deliv. Rev. 49: 265-280.
FU, Y., HOANG, A., ESCHER, G., PARTON, R. G., KROZOWSKI, Z. AND SVIRIDOV, D.
(2004) Expression of caveolin-1 enhances cholesterol efflux in hepatic cells.
J. Biol. Chem. 279: 14140-14146.
OKAMOTO, T., SCHLEGEL, A., SCHERER, P. E. AND LISANTI, M. P. (1998) Caveolins,
a family of scaffolding proteins for organizing «preassembled signaling com-
plexes» at the plasma membrane. J. Biol. Chem. 273: 5419-5422.
DEL POZO, M. A., BALASUBRAMANIAN, N., ALDERSON, N. B., KIOSSES, W. B., GRAN-
DE-GARCIA, A., ANDERSON, R. G. AND SCHWARTZ, M. A. (2005) Phospho-caveolin-
1 mediates integrin-regulated membrane domain internalization. Nat. Cell
Biol. 7: 901-908.
WILLIAMS, T. M. AND LISANTI, M. P. (2005) Caveolin-1 in oncogenic transfor-
mation, cancer, and metastasis. Am. J. Physiol. Cell. Physiol. 288: C494-506.
DRAB, M., VERKADE, P., ELGER, M., KASPER, M., LOHN, M., LAUTERBACH, B.,
MENNE, J., LINDSCHAU, C., MENDE, F., LUFT, F. C., ET AL. (2001) Loss of caveo-
lae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrup-
ted mice. Science 293: 2449-2452.
GALBIATI, F., ENGELMAN, J. A., VOLONTE, D., ZHANG, X. L., MINETTI, C., LI, M.,
HOU, H., JR., KNEITZ, B., EDELMANN, W. AND LISANTI, M. P. (2001) Caveolin-3
null mice show a loss of caveolae, changes in the microdomain distribution
of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J. Biol.
Chem. 276: 21425-21433.
RAZANI, B., ENGELMAN, J. A., WANG, X. B., SCHUBERT, W., ZHANG, X. L., MARKS,
C. B., MACALUSO, F., RUSSELL, R. G., LI, M., PESTELL, R. G., ET AL. (2001)
Caveolin-1 null mice are viable but show evidence of hyperproliferative and
vascular abnormalities. J. Biol. Chem. 276: 38121-38138.

1116